NASHNEXT

Welcome to the Brand page for “NASHNEXT”, which is offered here for Downloadable software for diagnosis of metabolic disorders and liver diseases and in permitting the transmission and exchange of biological data; scientific and instruments in the nature of laboratory devices for detecting genetic and protein sequences, sequencers, genetic analyser machines, biochips, immunoassays, microfluidic platforms, for detecting genomics/proteomics data, quantitative pcr and readers, for integrating and analyzing the data generated from experimental biology, diseases data and patient clinical data, informatics management system, for recording, quantifying, treating, reproducing, transmitting data, in the field of clinical research and diagnostics of metabolic disorders and liver diseases for use in genetic and enzymatic research;pharmaceutical preparations for the prevention, diagnosis, monitoring and imaging of metabolic disorders and liver diseases; diagnostic preparations and diagnostic biomarker reagents for medical purposes; diagnostic tests for medical use, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood and blood derived samples, plasma, serum, platelet free samples;nash next;diagnostic preparations for scientific use; chemical reagents for industrial use, other than for medical or veterinary purpose; chemical reagents for scientific research purposes;medical analysis services for the diagnosis of liver diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, immune diseases and cancers; blood sample analysis services; medical assistance services; medical information in the field of metabolic disorders and liver diseases;medical apparatuses for measuring metabolic disorders and liver diseases, non-invasive diagnostic apparatus and instruments for detecting metabolic disorders and liver diseases; medical diagnostic apparatus, medical devices for diagnosis of metabolic disorders and liver diseases, blood analysis apparatus, dna and rna analysis apparatus, gene analyzer, medical devices for measuring the evaluation of metabolic disorders and liver diseases, and blood analysis tools for evaluation of metabolic disorders and liver diseases;biological research; clinical medical research; computer programming; computer software design for others; laboratory research services relating to pharmaceuticals in the field of metabolic disorders and liver diseases; industrial research services in the field of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “NASHNEXT” is believed to be currently owned by “Genfit”.